![](/img/cover-not-exists.png)
Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group
Katodritou, Eirini, Terpos, Evangelos, Kelaidi, Charikleia, Kotsopoulou, Maria, Delimpasi, Sossana, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikos, Stefanoudaki, Aikaterini, ChriVolume:
89
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.23600
Date:
February, 2014
File:
PDF, 494 KB
english, 2014